Since retinoic acid-related orphan receptor-γ (RORγt) is the main regulator of Th17 differentiation, RORγt inhibitors (in development for autoimmune diseases) could potentially reduce Th17 cell generation in endometriosis and thus decrease IL-17-mediated pathology (196). Here, IL17A is linked to endometriosis.